Richard Stanley Bedlack
Stewart, Hughes and Wendt Distinguished Professor · Duke University School of Medicine
Credentials: ·
History
- Present
Duke Institute for Brain Sciences
Research
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
Science · 2015 · 797 citations
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
The Lancet Neurology · 2007 · 527 citations
Dual-wavelength ratiometric fluorescence measurement of the membrane dipole potential
Biophysical Journal · 1994 · 210 citations
- GP
30 papers
24 papers
23 papers
23 papers
21 papers · 20 as a resident
21 papers
21 papers
- TB
21 papers
Clinical trials
- 2026–2027
Pilot Trial Utilizing β-hydroxy-β-methylbutyrate to Lower IGFBP7 Levels in People With ALS
Principal investigator · Not yet recruiting · Phase 1
Duke University
- 2026
Intestinal Microbiome Transplant in ALS
Principal investigator · Recruiting · Phase 1, Phase 2
Duke University
- 2020–2022
Trial of Theracurmin for Patients With Amyotrophic Lateral Sclerosis (ALS)
Principal investigator · Completed · Phase 2
Richard Bedlack, M.D., Ph.D.
- 2018–2019
A Pilot Trial of Triheptanoin for People With Amyotrophic Lateral Sclerosis (PALS)
Principal investigator · Completed · Phase 1, Phase 2
Richard Bedlack, M.D., Ph.D.